Prospera Financial Services Inc Charles River Laboratories International, Inc. Transaction History

Prospera Financial Services Inc

  • $3.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023
BUY
$183.71 - $210.25 $179,117 - $204,993
975 New
975 $204,000
Q4 2022

Feb 08, 2023
BUY
$197.11 - $250.07 $189,225 - $240,067
960 New
960 $209,000
Q2 2022

Aug 08, 2022
SELL
$204.13 - $302.4 $34,089 - $50,500
-167 Reduced 17.78%
772 $165,000
Q1 2022

May 04, 2022
BUY
$255.51 - $362.11 $239,923 - $340,021
939 New
939 $267,000

Others Institutions Holding CRL

# of Institutions
698
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email